[HTML][HTML] How Taiwan has responded to COVID-19 and how COVID-19 has affected Taiwan, 2020–2022

CC Lai, PI Lee, PR Hsueh - Journal of Microbiology, Immunology and …, 2023 - Elsevier
Abstract From January 2020 to December 2022, there was a total of 8,872,955 confirmed
COVID-19 cases in Taiwan. In addition, a total of 15,253 COVID-19 related deaths were …

Medicinal herbs in the relief of neurological, cardiovascular, and respiratory symptoms after COVID-19 infection a literature review

J Nawrot, J Gornowicz-Porowska, J Budzianowski… - Cells, 2022 - mdpi.com
COVID-19 infection causes complications, even in people who have had a mild course of
the disease. The most dangerous seem to be neurological ailments: anxiety, depression …

[HTML][HTML] The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19

X An, YH Zhang, L Duan, D Jin, S Zhao… - Biomedicine & …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the third coronavirus
causing serious human disease to spread across the world in the past 20 years, after SARS …

[HTML][HTML] A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies

CX Li, S Noreen, LX Zhang, M Saeed, PF Wu… - Biomedicine & …, 2022 - Elsevier
Coronavirus is a family of viruses that can cause diseases such as the common cold, severe
acute respiratory syndrome (SARS), and Middle East respiratory syndrome (MERS). The …

Targeting spike protein-induced TLR/NET axis by COVID-19 therapeutic NRICM102 ameliorates pulmonary embolism and fibrosis

WC Wei, CC Liaw, KC Tsai, CT Chiou, YH Tseng… - Pharmacological …, 2022 - Elsevier
The global COVID-19 pandemic remains a critical public health threat, as existing vaccines
and drugs appear insufficient to halt the rapid transmission. During an outbreak from May to …

COVID-19 therapeutic potential of natural products

Z Low, R Lani, V Tiong, C Poh, S AbuBakar… - International Journal of …, 2023 - mdpi.com
Despite the fact that coronavirus disease 2019 (COVID-19) treatment and management are
now considerably regulated, severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

[HTML][HTML] The exploration of phytocompounds theoretically combats SARS-CoV-2 pandemic against virus entry, viral replication and immune evasion

TH Chen, MJ Tsai, CS Chang, L Xu, YS Fu… - Journal of Infection and …, 2023 - Elsevier
Background The novel coronavirus disease-2019 (COVID-19) that emerged in China, is an
extremely contagious and pathogenic viral infection caused by the severe acute respiratory …

Efficacy analysis and research progress of complementary and alternative medicines in the adjuvant treatment of COVID-19

JG Lin, GJ Huang, YC Su - Journal of Biomedical Science, 2023 - Springer
Abstract The coronavirus disease 2019 (COVID-19) pandemic has impacted human
lifestyles around the world, causing huge distress in terms of public health systems …

Chinese herbal prescriptions for COVID-19 management: Special reference to Taiwan Chingguan Yihau (NRICM101)

YC Su, GJ Huang, JG Lin - Frontiers in Pharmacology, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a strain of coronavirus
that causes COVID-19 (coronavirus disease 2019), the respiratory illness responsible for the …

1H NMR-Based Biochemometric Analysis of Morus alba Extracts toward a Multipotent Herbal Anti-Infective

J Langeder, K Döring, H Schmietendorf… - Journal of Natural …, 2022 - ACS Publications
Mulberry Diels–Alder-type adducts (MDAAs) derived from the white mulberry tree were
discovered recently as dual inhibitors of influenza viruses and pneumococci. For the …